Instil Bio, Inc.
TIL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001789769
No open-market purchases or sales by Instil Bio, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $29.2M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Instil Bio, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 34 | 29 | −5 |
| Shares | 4.55M | 4.44M | −111.5K (−2.4%) |
| Value | $81.3M | $48.9M | −$32.5M (−39.9%) |
New holders (6)
Institutions that held Instil Bio, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 67,800 | $745.8K | 0.00% |
| Nomura Asset Management International Inc. | 50,000 | $550.0K | 0.00% |
| Citadel Advisors LLC | 47,335 | $520.7K | 0.00% |
| Quadrature Capital Ltd | 19,198 | $211.2K | 0.00% |
| XTX Topco Ltd | 12,267 | $134.9K | 0.00% |
| Eq Wealth Advisors, LLC | 40 | $440 | 0.00% |
Sold out (11)
Institutions that held Instil Bio, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Sectoral Asset Management Inc | 161,380 | $2.88M |
| Boxer Capital Management, LLC | 60,700 | $1.08M |
| Macquarie Group Ltd | 50,000 | $893.0K |
| Marshall Wace, LLP | 44,878 | $801.5K |
| Jane Street Group, LLC | 20,802 | $371.5K |
| Northern Trust Corp | 15,684 | $280.1K |
| Tower Research Capital LLC (TRC) | 3,134 | $56.0K |
| Bokf, NA | 454 | $8.11K |
| FMR LLC | 5 | $94 |
| Citigroup Inc | 1 | $18 |
| SBI Securities Co., Ltd. | 1 | $18 |